In order to investigate the potential involvement of HDACs in the migration of lung cancer cells, we conducted an examination of the effects of two HDAC inhibitors, trichostatin A (TSA) and sodium butyrate (NaBu), which are structurally unrelated. This evidence concerns the gene HDAC9 and lung cancer.